Martin Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10,077
| Closed | -$517K | – | 49 |
|
|
2023
Q4 | $517K | Sell |
10,077
-108,522
| -92% | -$5.57M | 0.15% | 38 |
|
|
2023
Q3 | $6.88M | Sell |
118,599
-5,454
| -4% | -$317K | 2.06% | 18 |
|
|
2023
Q2 | $7.93M | Sell |
124,053
-3,709
| -3% | -$237K | 2.24% | 16 |
|
|
2023
Q1 | $8.86M | Buy |
127,762
+9,607
| +8% | +$666K | 2.55% | 15 |
|
|
2022
Q4 | $8.5M | Buy |
118,155
+2,929
| +3% | +$211K | 2.67% | 10 |
|
|
2022
Q3 | $8.19M | Buy |
115,226
+1,074
| +0.9% | +$76.3K | 2.87% | 11 |
|
|
2022
Q2 | $8.79M | Sell |
114,152
-1,668
| -1% | -$128K | 2.49% | 12 |
|
|
2022
Q1 | $8.46M | Buy |
115,820
+6,061
| +6% | +$443K | 2.14% | 19 |
|
|
2021
Q4 | $6.84M | Sell |
109,759
-10,626
| -9% | -$662K | 1.7% | 24 |
|
|
2021
Q3 | $7.12M | Buy |
120,385
+570
| +0.5% | +$33.7K | 1.8% | 23 |
|
|
2021
Q2 | $8.01M | Buy |
119,815
+320
| +0.3% | +$21.4K | 2.06% | 17 |
|
|
2021
Q1 | $7.54M | Buy |
119,495
+12,322
| +11% | +$778K | 2.13% | 19 |
|
|
2020
Q4 | $6.65M | Sell |
107,173
-1,284
| -1% | -$79.6K | 2.12% | 19 |
|
|
2020
Q3 | $6.54M | Buy |
108,457
+4,975
| +5% | +$300K | 2.36% | 18 |
|
|
2020
Q2 | $6.09M | Buy |
103,482
+1,462
| +1% | +$86K | 2.54% | 17 |
|
|
2020
Q1 | $5.69M | Sell |
102,020
-24,767
| -20% | -$1.38M | 2.88% | 12 |
|
|
2019
Q4 | $8.14M | Sell |
126,787
-106,244
| -46% | -$6.82M | 2.82% | 12 |
|
|
2019
Q3 | $11.8M | Buy |
233,031
+962
| +0.4% | +$48.8K | 2.89% | 19 |
|
|
2019
Q2 | $10.5M | Buy |
+232,069
| New | +$10.5M | 2.64% | 23 |
|